
Wednesday, August 24, 2022 10:45:17 AM
#GamidaCell COO/CCO Michele Korfin joins #PrecisionADVANCE and #EndpointsNews at Cell&Gene Day to discuss curative approaches with innovative cell therapies and their value propositions, patient access, and health equity.
— Gamida Cell (@GamidaCellTx) August 24, 2022
Learn More: https://t.co/074tjcQg9N #omidubicel pic.twitter.com/J0pYt1JrjA

Liked By
Spread the love. Be the first to like this post!
Recent GMDA News
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 03/22/2023 08:35:41 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/20/2023 08:46:51 PM
- Gamida Cell Announces Changes to Board of Directors • Business Wire • 03/20/2023 08:30:00 PM
- Gamida Cell Announces the Date of Its Fourth Quarter and Full Year 2022 Financial Results and Webcast • Business Wire • 03/20/2023 12:00:00 PM
- Gamida Cell to Present Corporate Highlights at the Oppenheimer 33rd Annual Healthcare Conference • Business Wire • 03/07/2023 01:00:00 PM
- Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 03/03/2023 09:03:47 PM
- Data Presented on Gamida Cell’s Omidubicel, GDA-201 at the 2023 Tandem Meetings of ASTCT and CIBMTR • Business Wire • 02/18/2023 05:30:00 PM
- Statement of Ownership (sc 13g) • Edgar (US Regulatory) • 02/14/2023 09:10:55 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/09/2023 04:02:40 PM
- Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 01/30/2023 12:03:54 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/30/2023 12:01:20 PM
- Notice of Effectiveness (effect) • Edgar (US Regulatory) • 01/23/2023 11:04:06 AM
- Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) • Edgar (US Regulatory) • 01/20/2023 09:32:22 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/19/2023 09:44:26 PM
- Proxy Statement (definitive) (def 14a) • Edgar (US Regulatory) • 01/10/2023 10:13:59 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/09/2023 05:16:06 PM
- Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) • Edgar (US Regulatory) • 12/30/2022 10:17:38 PM
- Analysts’ Top Healthcare Picks: Crispr Therapeutics AG (CRSP), Arcutis Biotherapeutics (ARQT) • TipRanks • 12/12/2022 06:11:45 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 12/12/2022 12:16:53 PM
- Gamida Cell Announces Closing of $25 Million Financing With Highbridge • Business Wire • 12/12/2022 12:00:00 PM
- Gamida Cell to Present Corporate Highlights at Multiple Upcoming Investor Conferences • Business Wire • 11/23/2022 01:00:00 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 11/22/2022 09:37:38 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 11/22/2022 09:35:07 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 11/22/2022 09:33:25 PM
- JMP Securities Remains a Buy on Gamida Cell (GMDA) • TipRanks • 11/22/2022 06:05:10 PM
Nextech3D.ai Announces Its AI-Powered SaaS Platform Toggle3D Experiences A +963% Jump in Users in 60-Days Crossing Over 1000 Users • NTAR • Mar 23, 2023 7:07 AM
Lifecycle Assessment by Benchmark Shows TMC's NORI-D Nodule Project Could Outperform Land-Based Routes of Producing Nickel, Copper and Cobalt in Almost Every Impact Category Analyzed • TMC • Mar 22, 2023 1:44 PM
Fineqia Announces Partnership with Paris Blockchain Week to Accelerate Digital Asset Innovation • FNQQF • Mar 22, 2023 10:03 AM
E-Cite and ClearMarket Launch Nationwide EV Distribution Network Becoming the First All EV Dealership Opening in the Cerritos Auto Square, the World's Largest Automall • VAPR • Mar 22, 2023 9:41 AM
Electromedical Announces $1.36M Net Proceeds from Building Sale to Fund WellnessPro Infinity ™ Launch and Convertible Note Retirement. • EMED • Mar 22, 2023 7:04 AM
HealthLynked Corp. Awarded Patent 11,600,395 for "Secure Patient Access via Healthcare Service Provider Specific Wireless Access Point" • HLYK • Mar 21, 2023 8:00 AM